snmjournals.org

Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas

Journal of Nuclear Medicine September 2025, jnumed.125.270115; DOI: https://doi.org/10.2967/jnumed.125.270115 ...
snmjournals.org

Interspecies Variability in Biodistribution and PET Imaging Performance of

Journal of Nuclear Medicine July 2025, jnumed.125.270069; DOI: https://doi.org/10.2967/jnumed.125.270069 ...
snmjournals.org

A Prospective Provincial Registry of

Journal of Nuclear Medicine July 2025, jnumed.125.269653; DOI: https://doi.org/10.2967/jnumed.125.269653 ...
snmjournals.org

225 Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer

Radioimmunotherapy using 225Ac, a highly cytotoxic α-particle emitter, has potential for treating advanced breast cancer, especially human epidermal growth factor receptor 2 (HER2)–positive cases. We ...
snmjournals.org

First-in-Human Serum Stability Studies of

Journal of Nuclear Medicine April 2025, jnumed.124.269132; DOI: https://doi.org/10.2967/jnumed.124.269132 ...
snmjournals.org

225 Ac/ 89 Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer

Nectin-4 is an overexpressed biomarker in 60%–70% of triple-negative breast cancer (TNBC) cases and an ideal target for radiotherapy and PET imaging. In this study, theranostic radioimmunoconjugates ...
snmjournals.org

Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes ...

The American Thyroid Association proposed a risk stratification system for disease recurrence for patients with differentiated thyroid cancer (DTC), that is, papillary thyroid cancer (PTC) and ...
snmjournals.org

First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...
snmjournals.org

Pilot Study of Nectin-4–Targeted PET Imaging Agent

Nectin cell adhesion molecule 4 (Nectin-4) is an emerging biomarker for cancer diagnosis and therapy. We developed a Nectin-4–targeted 68Ga-DOTA-Sar10-Nectin-4 (68Ga-FZ-NR-1) PET/CT radiotracer for ...
snmjournals.org

CD70-Targeted Immuno-PET/CT Imaging of Clear Cell Renal Cell Carcinoma: A Translational Study

The diagnosis and surveillance of clear cell renal cell carcinoma (ccRCC) remains a clinical challenge. The high and specific expression of the cluster of differentiation 70 (CD70) in ccRCC makes it a ...
snmjournals.org

The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice

Nuclear medicine for therapeutic purposes, here termed molecular radiotherapy (MRT), is a rapidly developing field, mostly in the context of metastatic cancer treatment. It is self-evident that ...
snmjournals.org

Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine August 2024, jnumed.124.267922; DOI: https://doi.org/10.2967/jnumed.124.267922 ...